Table 1.
Data Description: Mean Values and 95% CIs for 41 Markers and 5 Groups.
| BEN | LPCa | META | WAP | SM_CL | ||||||
| Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | |
| ABP280 | 0.65 | 0.69 | 0.42 | 1.02 | -1.61 | 0.71 | -0.63 | 1.46 | -0.57 | 0.02 |
| AMACR | -0.87 | 0.22 | 0.76 | 1.05 | -0.20 | 2.05 | 0.64 | 2.82 | -0.36 | 0.32 |
| AR | 0.33 | 1.77 | 0.37 | 1.57 | -0.40 | 1.97 | -0.44 | 2.14 | -1.73 | 1.09 |
| BM28 | -0.63 | 0.44 | 0.11 | 1.41 | 0.07 | 2.98 | 0.54 | 1.90 | 2.27 | 1.64 |
| BUB3 | 0.01 | 0.73 | 0.42 | 1.10 | -0.13 | 2.83 | -0.82 | 3.35 | 0.27 | 1.73 |
| CaMKK | 0.03 | 1.45 | 0.18 | 0.86 | 0.18 | 2.99 | -0.05 | 3.08 | -0.55 | 0.95 |
| CASPASE3 | 1.00 | 0.89 | -0.30 | 1.15 | -0.17 | 1.94 | -1.35 | 0.84 | -1.03 | 0.68 |
| CDK7 | 0.18 | 1.09 | 0.33 | 1.47 | -0.58 | 2.39 | 0.19 | 3.00 | -1.84 | 1.30 |
| DYNAMIN | 0.10 | 1.32 | 0.73 | 1.05 | -0.74 | 1.80 | -0.83 | 2.25 | 0.25 | 2.74 |
| E2F-1 | -0.15 | 1.16 | 0.07 | 1.22 | 0.46 | 2.70 | -0.56 | 2.02 | -0.12 | 5.72 |
| E-cadherin | -0.03 | 1.33 | 0.31 | 1.48 | -0.66 | 2.00 | 0.64 | 2.13 | -2.42 | 1.93 |
| EXPORTIN | 0.02 | 1.25 | 0.24 | 1.44 | -0.18 | 2.41 | -0.21 | 3.96 | -0.40 | 0.95 |
| EZH2 | -0.46 | 0.83 | 0.08 | 1.31 | 0.00 | 2.24 | 0.45 | 1.76 | 2.77 | 3.89 |
| FAS | -0.28 | 2.00 | 0.08 | 1.58 | 0.22 | 2.54 | 0.47 | 2.40 | -0.49 | 1.15 |
| GAS7 | 0.20 | 1.54 | -0.09 | 1.49 | 0.05 | 2.27 | 0.24 | 2.83 | 0.12 | 3.13 |
| GS28 | 0.18 | 0.84 | 0.28 | 0.91 | 0.34 | 0.53 | -1.00 | 4.36 | -0.53 | 2.19 |
| ICBP90 | -0.42 | 0.98 | 0.58 | 1.86 | -0.47 | 2.30 | -0.46 | 1.23 | 1.95 | 2.58 |
| ITGA5 | 0.15 | 1.14 | 0.18 | 1.25 | -1.34 | 1.31 | 0.31 | 1.42 | -0.40 | 0.43 |
| Jagged 1 | -0.77 | 0.71 | -0.30 | 0.47 | 1.11 | 0.98 | 1.23 | 2.20 | 1.15 | 0.74 |
| JAM1 | -0.03 | 1.16 | 0.06 | 0.85 | -1.24 | 2.43 | 0.75 | 1.37 | 1.56 | 3.48 |
| KANADAPTIN | -0.61 | 1.22 | 0.23 | 1.12 | -0.24 | 1.69 | 1.66 | 1.34 | -1.54 | 1.25 |
| KLF6 | -0.09 | 1.41 | -0.05 | 1.24 | -0.62 | 2.66 | 1.11 | 2.60 | -0.02 | 2.50 |
| KRIP1 | -0.35 | 1.43 | 0.33 | 1.58 | 0.02 | 1.66 | -0.15 | 1.90 | 1.57 | 6.30 |
| LAP2 | -0.10 | 0.90 | -0.02 | 1.14 | -0.71 | 2.75 | 0.92 | 2.39 | 1.18 | 4.18 |
| MCAM | -0.40 | 0.86 | 0.05 | 1.50 | 0.93 | 2.72 | -0.16 | 2.38 | -1.32 | 1.42 |
| MIB1 (MKi67) | -0.49 | 0.11 | -0.17 | 0.52 | -0.36 | 0.44 | 1.21 | 3.31 | 3.05 | 0.79 |
| MTA1 | -0.25 | 1.04 | 0.67 | 0.93 | -0.99 | 2.33 | 0.38 | 2.91 | -0.32 | 2.51 |
| MUC1 | -0.33 | 0.26 | -0.30 | 1.28 | -0.24 | 0.87 | 1.16 | 3.21 | 2.75 | 0.71 |
| Myosin VI | -0.48 | 1.04 | 0.24 | 1.73 | 0.58 | 2.10 | 0.49 | 2.66 | -1.40 | 0.68 |
| P27 | 0.62 | 1.42 | 0.20 | 1.78 | -0.26 | 2.05 | -1.30 | 1.06 | 0.04 | 0.11 |
| P63 | 1.30 | 0.48 | -0.76 | 0.26 | -0.77 | 0.24 | -0.27 | 1.84 | -0.34 | 0.48 |
| PAXILLIN | 0.01 | 1.49 | 0.32 | 2.30 | -0.92 | 0.95 | 0.31 | 2.50 | 0.18 | 1.08 |
| PLCLN | -0.51 | 0.73 | 0.63 | 1.21 | 0.05 | 3.16 | -0.29 | 2.27 | 0.04 | 3.39 |
| PSA (KLK3) | 0.65 | 0.18 | 0.36 | 0.54 | -0.27 | 1.84 | -1.48 | 1.99 | -2.57 | 0.07 |
| RAB27 | 0.79 | 0.50 | 0.30 | 1.44 | -0.95 | 1.78 | -1.16 | 0.64 | -1.62 | 0.27 |
| RBBP | 0.33 | 1.37 | 0.16 | 1.44 | 0.01 | 2.21 | -0.75 | 3.52 | -0.60 | 0.52 |
| RIN1 | 1.00 | 0.54 | 0.35 | 1.36 | -1.16 | 0.51 | -1.13 | 0.46 | -1.11 | 0.25 |
| SAPK alpha | -0.05 | 1.18 | 0.05 | 0.99 | -0.09 | 2.78 | 0.22 | 3.14 | 1.36 | 2.75 |
| TPD52 | -0.11 | 0.71 | -0.04 | 1.35 | 1.22 | 2.42 | -1.05 | 2.44 | 0.05 | 1.32 |
| XIAP | -0.43 | 1.28 | 0.74 | 1.02 | -0.90 | 1.58 | 0.58 | 2.35 | -1.63 | 0.04 |
| ZAG | 0.42 | 1.14 | 0.34 | 2.17 | -0.93 | 1.58 | -0.42 | 1.76 | -1.33 | 0.19 |
Key: BEN= benign prostate tissue; LPCA=clinically localized prostate cancer; META= hormone naive metastatic prostate cancer; WAP=hormone refractory metastatic prostate cancer; SM_CL= small cell prostate cancer.